Confo Therapeutics News and Activities

Acquisition, funding and merger involving Confo Therapeutics.

• Confo Therapeutics has just announced a $60 Million fundraising (posted on July 30 2024).

View the org chart displaying its 13 main executives

Most searched biographies at Confo Therapeutics

• Cedric Ververken, Chief Executive Officer and Director
• Filip Goossens, Director
• Caroline Goddeeris, Director

Create your alert
to follow the executive moves at Confo Therapeutics.

Confo Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Confo Therapeutics

• Latest news - Confo Therapeutics
• Press Releases – Confo Therapeutics

Social media about Confo Therapeutics

• Confo Therapeutics on Wikipedia, Google News & Yahoo Finance
• Confo Therapeutics on LinkedIn, X (Twitter) & YouTube